Academic · Private company
Barbara Ann Karmanos Cancer Institute
Track this companyFree. Adds Barbara Ann Karmanos Cancer Institute to your Dealase workspace and tells you when its record changes.
Clinical trials2524 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials25
- Ask Questions About Clinical TrialsNA · RECRUITING · started Dec 30, 2026ClinicalTrials.gov NCT07343297 · fetched Nov 12, 2026
- MyPatientPal+: A Smartphone App and a Provider Dashboard to Manage Patient Care While on TreatmentNA · NOT_YET_RECRUITING · started Nov 1, 2026ClinicalTrials.gov NCT07928154 · fetched Nov 12, 2026
- A Study of the TheraBionic P1 Device in Breast CancerNA · RECRUITING · started Oct 1, 2026ClinicalTrials.gov NCT07218432 · fetched Nov 12, 2026
- Sequential Toripalimab and Paclitaxel in Patients With Head and Neck Squamous Cell Cancer (HNSCC) and Poor Performance StatusPHASE2 · NOT_YET_RECRUITING · started Sep 30, 2026ClinicalTrials.gov NCT07796126 · fetched Nov 12, 2026
- Study of the TheraBionic P1 Device in Patients With Metastatic Triple Negative Breast Cancer After ProgressionNA · NOT_YET_RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07672431 · fetched Nov 12, 2026
- Impact of Duffy-null Associated Neutropenia on Chemotherapy DosingPHASE1_PHASE2 · NOT_YET_RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07743086 · fetched Nov 12, 2026
- Positron Emission Tomography/Computed Tomography (PET/CT) Imaging in Patients Diagnosed With a GliomaPHASE2 · NOT_YET_RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07735819 · fetched Nov 12, 2026
- Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer SurvivorsNA · RECRUITING · started Apr 18, 2026ClinicalTrials.gov NCT07436078 · fetched Nov 12, 2026
- A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast CancerNA · RECRUITING · started Jan 16, 2026ClinicalTrials.gov NCT07227831 · fetched Nov 12, 2026
- TheraBionic P1 Device in Subjects With Advanced Hepatocellular CarcinomaNA · RECRUITING · started Oct 20, 2025ClinicalTrials.gov NCT07118202 · fetched Nov 12, 2026
- Metformin Combined With Chemotherapy and/or Immunotherapy in Solid MalignanciesPHASE1 · RECRUITING · started Sep 18, 2025ClinicalTrials.gov NCT07098299 · fetched Nov 12, 2026
- Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal CancerPHASE2 · RECRUITING · started Sep 10, 2025ClinicalTrials.gov NCT07130903 · fetched Nov 12, 2026
- A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.NA · RECRUITING · started Aug 18, 2025ClinicalTrials.gov NCT07095114 · fetched Nov 12, 2026
- Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic CancerPHASE2 · RECRUITING · started Feb 28, 2025ClinicalTrials.gov NCT06576115 · fetched Nov 12, 2026
- Addressing Social Determinants of Health Among Metro Detroit Cancer SurvivorsNA · RECRUITING · started Sep 3, 2024ClinicalTrials.gov NCT06908629 · fetched Nov 12, 2026
- DapagliFLOzin in Renal AL Amyloidosis (FLORAL)PHASE2 · RECRUITING · started Jul 11, 2024ClinicalTrials.gov NCT06420167 · fetched Nov 12, 2026
- Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple MyelomaPHASE2 · RECRUITING · started Dec 21, 2023ClinicalTrials.gov NCT06107738 · fetched Nov 12, 2026
- Dietary Reporting In The AmyloidosesNA · RECRUITING · started Mar 2, 2023ClinicalTrials.gov NCT05738005 · fetched Nov 12, 2026
- A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through Improved Treatment Cost DiscussionsNA · ACTIVE_NOT_RECRUITING · started Dec 9, 2022ClinicalTrials.gov NCT07042191 · fetched Nov 12, 2026
- F-Tryptophan PET/CT in Human CancersPHASE1 · COMPLETED · started Sep 29, 2022ClinicalTrials.gov NCT05556473 · fetched Nov 12, 2026
- Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated LymphomaPHASE2 · ACTIVE_NOT_RECRUITING · started Aug 21, 2020ClinicalTrials.gov NCT04479267 · fetched Nov 12, 2026
- C.A.P.A.B.L.E. (CrossFit® and Physical Activity: A Better Life Experience)NA · RECRUITING · started Nov 12, 2018ClinicalTrials.gov NCT03750981 · fetched Nov 12, 2026
- Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin LymphomaPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jun 20, 2017ClinicalTrials.gov NCT03147885 · fetched Nov 12, 2026
- Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung CancerNA · ACTIVE_NOT_RECRUITING · started Aug 1, 2014ClinicalTrials.gov NCT02178163 · fetched Nov 12, 2026
- 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With CancerACTIVE_NOT_RECRUITING · started Sep 1, 2009ClinicalTrials.gov NCT00935090 · fetched Nov 12, 2026